1. Home
  2. BCAB vs STRM Comparison

BCAB vs STRM Comparison

Compare BCAB & STRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • STRM
  • Stock Information
  • Founded
  • BCAB 2007
  • STRM 1989
  • Country
  • BCAB United States
  • STRM United States
  • Employees
  • BCAB N/A
  • STRM N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • STRM EDP Services
  • Sector
  • BCAB Health Care
  • STRM Technology
  • Exchange
  • BCAB Nasdaq
  • STRM Nasdaq
  • Market Cap
  • BCAB 22.3M
  • STRM 22.3M
  • IPO Year
  • BCAB 2020
  • STRM 1996
  • Fundamental
  • Price
  • BCAB $0.41
  • STRM $5.19
  • Analyst Decision
  • BCAB Buy
  • STRM
  • Analyst Count
  • BCAB 2
  • STRM 0
  • Target Price
  • BCAB $1.00
  • STRM N/A
  • AVG Volume (30 Days)
  • BCAB 561.7K
  • STRM 198.4K
  • Earning Date
  • BCAB 08-07-2025
  • STRM 06-16-2025
  • Dividend Yield
  • BCAB N/A
  • STRM N/A
  • EPS Growth
  • BCAB N/A
  • STRM N/A
  • EPS
  • BCAB N/A
  • STRM N/A
  • Revenue
  • BCAB $11,000,000.00
  • STRM $18,381,000.00
  • Revenue This Year
  • BCAB N/A
  • STRM $18.64
  • Revenue Next Year
  • BCAB N/A
  • STRM N/A
  • P/E Ratio
  • BCAB N/A
  • STRM N/A
  • Revenue Growth
  • BCAB N/A
  • STRM N/A
  • 52 Week Low
  • BCAB $0.24
  • STRM $1.82
  • 52 Week High
  • BCAB $2.53
  • STRM $9.45
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 44.32
  • STRM 82.91
  • Support Level
  • BCAB $0.38
  • STRM $5.14
  • Resistance Level
  • BCAB $0.46
  • STRM $5.24
  • Average True Range (ATR)
  • BCAB 0.06
  • STRM 0.03
  • MACD
  • BCAB -0.01
  • STRM -0.03
  • Stochastic Oscillator
  • BCAB 9.36
  • STRM 50.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About STRM Streamline Health Solutions Inc.

Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.

Share on Social Networks: